Source:http://linkedlifedata.com/resource/pubmed/id/19969510
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions |
umls-concept:C0005516,
umls-concept:C0013227,
umls-concept:C0037813,
umls-concept:C0040549,
umls-concept:C0185125,
umls-concept:C0205234,
umls-concept:C0282443,
umls-concept:C0332185,
umls-concept:C0392762,
umls-concept:C0596751,
umls-concept:C0599748,
umls-concept:C0936012,
umls-concept:C1552617,
umls-concept:C1948027,
umls-concept:C2347026
|
pubmed:issue |
2
|
pubmed:dateCreated |
2010-2-4
|
pubmed:abstractText |
Immunoaffinity chromatography (IAC), mass spectrometry and especially tandem mass spectrometry (MS/MS) represent the most efficient and reliable analytical techniques for specific isolation, unequivocal identification and accurate quantification of numerous natural and synthetic substances in biological samples. This review article focuses on the combined use of these outstanding methodologies in basic and clinical research and in life sciences for the quantitative analysis of low- and high-molecular mass biomarkers, drugs and toxins in urine, plasma or serum samples, in tissue and other biologicals systems published in the last decade. The analytes discussed in some detail include the biomarkers of oxidative stress 15(S)-8-iso-prostaglandin F(2alpha) {15(S)-8-iso-PGF(2alpha)} and 3-nitrotyrosine, the major urinary metabolite of the lipid mediators cysteinyl leukotrienes, i.e., the leukotriene E(4) (LTE(4)), melatonin, and the major collagen type II neoepitope peptide in human urine.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/3-nitrotyrosine,
http://linkedlifedata.com/resource/pubmed/chemical/Biological Markers,
http://linkedlifedata.com/resource/pubmed/chemical/Eicosanoids,
http://linkedlifedata.com/resource/pubmed/chemical/Pharmaceutical Preparations,
http://linkedlifedata.com/resource/pubmed/chemical/Toxins, Biological,
http://linkedlifedata.com/resource/pubmed/chemical/Tyrosine
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jan
|
pubmed:issn |
1873-376X
|
pubmed:author | |
pubmed:copyrightInfo |
2009 Elsevier B.V. All rights reserved.
|
pubmed:issnType |
Electronic
|
pubmed:day |
15
|
pubmed:volume |
878
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
133-48
|
pubmed:meshHeading |
pubmed-meshheading:19969510-Animals,
pubmed-meshheading:19969510-Biological Markers,
pubmed-meshheading:19969510-Chromatography, Affinity,
pubmed-meshheading:19969510-Eicosanoids,
pubmed-meshheading:19969510-Humans,
pubmed-meshheading:19969510-Immunosorbent Techniques,
pubmed-meshheading:19969510-Mass Spectrometry,
pubmed-meshheading:19969510-Pharmaceutical Preparations,
pubmed-meshheading:19969510-Toxins, Biological,
pubmed-meshheading:19969510-Tyrosine
|
pubmed:year |
2010
|
pubmed:articleTitle |
Quantitative analysis of biomarkers, drugs and toxins in biological samples by immunoaffinity chromatography coupled to mass spectrometry or tandem mass spectrometry: A focused review of recent applications.
|
pubmed:affiliation |
Institute of Clinical Pharmacology, Hannover Medical School, Germany. tsikas.dimitros@mh-hannover.de
|
pubmed:publicationType |
Journal Article,
Review
|